AMY BOISON: Open Payments
NPI 1750941845 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,032 in 69 payments from 11 companies in 2025. Trend: 2023 $765 · 2024 $746 · 2025 $2,032
Food & beverage: $1,930Education: $101
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $484 |
| Teva Pharmaceuticals USA, Inc. | 12 | $392 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $390 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $270 |
| Alkermes, Inc. | 7 | $165 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $87 |
| Corium, LLC | 3 | $86 |
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| Collegium Pharmaceutical, Inc. | 2 | $47 |
| ABBVIE INC. | 1 | $16 |
Products named: Auvelity, CAPLYTA, AUSTEDO XR, TRINTELLIX, ARISTADA, REJOYN, Azstarys, REXULTI.
Industry payments across NC — which companies pay providers there.
